Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Distributed may restore surrounding skin through

Complete may restore surrounding skin out to three times their own . Equivalent recovery from would refute the need for the full cellular set; effects confined to would refute the proposed sufficiency of replacing 13,4% of the area.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

The biological function description is being prepared

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Candidate set selection
Goal
Определение терапии с полным и устойчивым восстановлением функций кожи
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
5 / 10Clarity of mechanism
5 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
8 / 10Few new entities
7 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Organ structure

    Skin tissue

    Tissue comprising the epidermis, dermis and skin appendages, with vascular and nerve connections

    Where this hypothesis actsAgeing skin across the treatment area

    Hypotheses on this target 4
    Skin tissueFunction restoration. Hypotheses on this target 22Remodelling. Hypotheses on this target 0Tissue graft. Hypotheses on this target 22Load normalisation. Hypotheses on this target 0
    • Function restoration2
    • Remodelling
    • Tissue graft2
    • Load normalisation

    What is proposed

    Tissue graft

    Partially replace skin with complete, spatially distributed microtransplants

    With whatPhysical or surgical intervention

    HowIntegrate complete skin microtransplants on a triangular grid, replacing about 13.4% of the area; replace lost units at most annually without increasing their initial number

    Possible result

    Possible restoration of skin functions throughout the area, extending to three graft radii around each unit

    From the recordМинимальный достаточный набор представляет собой пространственно распределённые полноценные микротрансплантаты кожи.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and beddingSkin tissue. Hypotheses on this target 4Skin tissue
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

The aim is to bring middle-aged human skin back to the functional condition of young skin and keep it there. The unexpected move is to replace only about 13.4% of the treated surface with small, complete skin units, on the proposal that each restores function beyond its own edges. That reach is a hypothesis generated by this pipeline, not a measured result.

The proposed mechanism, link by link
  1. Complete small skin supply the cells and structures proposed to be necessary for the full set of skin functions.
  2. The join the surrounding tissue and acquire working blood supply and nerve connections.
  3. Each integrated graft is proposed to restore nearby skin beyond the transplanted tissue itself, reaching three times the graft .
  4. Even spacing lets these proposed zones cover the treated surface; clustering leaves gaps beyond their reach.
  5. Annual mapping and replacement of lost units are proposed to preserve coverage without increasing the original graft count.
A picture for it

Small sprinklers can water a whole lawn without occupying much of it, provided their reach is wide enough and their positions leave no dry gaps. Bunching the same sprinklers together leaves dry spaces elsewhere.

Where the picture breaks: Sprinklers have a directly measurable flow and reach. The supplied material does not identify how a graft would restore all functions in neighbouring skin or establish that different functions share one circular boundary.

  1. Master questionstep 01 of 04

    Middle-aged human skin is the intended treatment target, with the functional condition of young skin as the desired outcome.

    Rests on: The supplied goal explicitly seeks a therapy that brings middle-aged skin to a youthful functional state.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Success means complete restoration of skin functions that lasts.

    Rests on: The goal supplies youthful function as the target; this stage interprets that target as complete and sustained restoration.

    Assumption

    The original goal does not specify completeness or duration. This stage takes both as requirements for success.

  3. Gap questionstep 03 of 04

    A sufficient treatment must be identified by comparing combinations, removing components one at a time, and following outcomes for ten years against standard care.

    Rests on: Complete restoration motivates comparing combinations and testing which components are necessary; sustained restoration motivates prolonged follow-up.

    Assumption

    The ten-year observation period, standard-care comparison, and component-removal strategy are chosen ways to test the preceding requirement. The earlier stages do not establish why these particular choices are sufficient.

  4. Hypothesisstep 04 of 04

    Small, spatially distributed skin are proposed as the minimum sufficient treatment. Each would contain cells that renew the surface, support-producing cells from the upper and deeper skin, a , the material surrounding and supporting cells, sweat glands, local immune cells, small blood vessels, and structures that can connect to nerves for sensation and automatic control. Hair-bearing regions would also require hair-producing structures and their associated oil glands. Each graft is predicted to restore function out to three times its own , the distance from its centre to its edge. On a large, approximately flat surface, placing graft centres in a repeating pattern of equilateral triangles would then require direct replacement of about 13.4% of the area, through the depth of the included structures. Edges and curved surfaces require separate coverage calculations. The proposed regimen is one staged placement course followed by into the surrounding skin, daily standard care, annual mapping, and at most one replacement session for lost units each year, without increasing the original number. Fewer units are predicted to leave uncovered areas; removing gland or nerve components is predicted to leave the corresponding functional deficits.

    Rests on: The preceding stage calls for a complete combination and tests of component necessity. The endpoint supplies a candidate combination, an explicit rationale that functioning cells must be supplied, and a surface-coverage calculation conditional on the proposed three- reach. These are the stated grounds for the proposal, not evidence that its biological predictions hold.

    Stated in the chain

What is carried, and what is not. Two screened sources speak to part of the first mechanism link: Nature Protocols (2022, S1) describes human , laboratory-grown three-dimensional skin tissues, with several skin structures but a fetal-like state rather than demonstrated complete adult function; Nature (2020, S2) reports laboratory skin self-assembly and skin reconstruction in a living organism, but does not establish complete graft composition or recovery of surrounding middle-aged human skin. Neither establishes the proposed outward reach, coverage fraction, maintenance schedule, or sequence from graft placement to complete lasting recovery.S1S2

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The original goal does not specify completeness or duration. This stage takes both as requirements for success.
  • Gap question. The ten-year observation period, standard-care comparison, and component-removal strategy are chosen ways to test the preceding requirement. The earlier stages do not establish why these particular choices are sufficient.
How a result here could mislead · 3
  • A better average result across a treated area could reflect strong function inside while the surrounding original skin remains impaired. That would be mistaken for the proposed outward restoration. What closes it: Measure the specified functions separately inside and in surrounding original skin at mapped distances from graft edges and centres. Define youthful reference values and the criterion for joint recovery before testing; the supplied material provides neither.
  • Worse recovery with clustered or missing a component could reflect poorer graft survival or connection to the host, rather than a fixed restoration or the missing component's specific function. What closes it: For the spacing comparison, match graft number and composition as proposed, and measure surviving graft locations and working blood and nerve connections. Component-removal comparisons also require comparable survival and of the remaining components before a functional deficit can establish component necessity.
  • Failure of repair without transplanted cells could be credited to the necessity of complete even if that treatment never achieved the rival's required repair of the surrounding material. What closes it: Verify that the rival treatment restores all three specified parts of the across the entire intended volume: the strength-bearing network, the elastic network, and the water-binding material. Compare the same functions over the same follow-up, with repair criteria fixed in advance; those criteria are not supplied.

What would make this wrong. If repair of the without transplanted cells achieved the same complete, sustained functional recovery, the claimed necessity of complete cellular would be false. If viable, functionally integrated restored only their own tissue, the outward-restoration mechanism and the approximately 13.4% coverage claim would fail. Recovery that extends beyond but does not reach three graft radii would refute the stated quantitative version without necessarily refuting every possible graft-based treatment.

What it would change. If the proposal held, complete youthful skin function could be restored across an area while directly replacing only about 13.4% of its surface, making graft composition and spacing central treatment variables. Work on the master question would then have to assess recovery in the original skin between and whether the specified maintenance preserves it. Success in a model would still leave human transfer, safety, and ten-year durability unestablished; even successful human restoration would not by itself prove that this is the minimum sufficient treatment without the component and rival comparisons.

Sources read · 8

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells. · Nature protocols · 2022

“By day ~130, the skin organoids reach full complexity and contain stratified skin layers, pigmented hair follicles, sebaceous glands, Merkel cells, and sensory neurons, recapitulating the cell composition and architecture of fetal skin tissue at week-18 of gestation.”

Does not settle: Источник описывает органоиды кожи человека, полученные in vitro, и их состав, сопоставимый с кожей плода на 18-й неделе гестации. Он не устанавливает эффективность пространственно распределённых микротрансплантатов, радиус восстановления R = 3a, плотность или число единиц, долю заменяемой площади, приживление, эккринные железы, сосудистый и иммунный компоненты, подключение вегетативной иннервации либо режим поддержания.

S2Partly answers it

Hair-bearing human skin generated entirely from pluripotent stem cells. · Nature · 2020

“Together, our results demonstrate that nearly complete skin can self-assemble in vitro and be used to reconstitute skin in vivo .”

Does not settle: Остаются открытыми восстановление окружающей кожи распределёнными микротрансплантатами у человека, состав минимальной функциональной единицы, эккринный и сосудистый компоненты, подключение вегетативной иннервации, радиус восстановления R = 3a, расчёт числа единиц, доля замещаемой площади и режим поддержания.

S3Background

A prenatal skin atlas reveals immune regulation of human skin morphogenesis. · Nature · 2024

“Our human prenatal skin fibroblasts did not significantly express papillary fibroblast markers (for example, COL13A1 ) (Extended Data Fig. ), which suggested that the distinction between papillary and reticular fibroblasts emerges after 17 PCW.”

Does not settle: Источник не исследует микротрансплантаты, их состав, приживление, восстановление окружающей кожи, радиус действия, плотность размещения, число этапов или поддерживающий режим.

S4Partly answers it

Hair Follicle Development in Mouse Pluripotent Stem Cell-Derived Skin Organoids. · Cell reports · 2018

“Together, these findings reveal that skin organoids produced in our culture system can generate HFs similar to those seen in late embryonic and early postnatal development, consisting of all major units including HF matrix, inner root, outer root, and dermal sheath layers.”

Does not settle: Источник описывает полученные in vitro органоиды кожи мыши и частично сформированные волосяные фолликулы. Он не устанавливает восстановление окружающей кожи после распределённой пересадки, состав полноценного микротрансплантата, его интеграцию, сосудистое или нервное подключение, эккринные железы, иммунные клетки, радиус восстановления, плотность размещения, число этапов или режим поддержания.

S5Background

Split-Thickness Skin Grafts · European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie · 2025

“When a graft includes only a portion of the dermis, it is called a split-thickness skin graft. When a graft contains the entire dermis, it is called a full-thickness skin graft.”

Does not settle: This review does not evaluate spatially distributed complete skin micrografts, the proposed cellular and glandular or neural components, restoration radius, graft spacing, number of units, replaced-area percentage, integration course, maintenance schedule, or restoration of surrounding skin function.

S8Partly answers it

Self-assembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration. · Theranostics · 2021

“Stratified human skin also self-assembled within two weeks after either adult- or iPSC-derived skin cell-suspension liquid-transplantation, healing deep wounds of mice.”

Does not settle: Источник описывает трансплантацию суспензии трёх типов клеток в глубокие раны иммунодефицитных мышей. Он не устанавливает состав полноценных микротрансплантатов с эккринными железами, иммунными клетками, нервными структурами или фолликулярно-сальными модулями, радиус восстановления R = 3a, плотность размещения, долю заменяемой площади, режим повторной замены или восстановление функций кожи у человека.

S9Partly answers it

Mechanical stimuli-induced CCL2 restores adult mouse cells to regenerate hair follicles. · Molecular therapy. Nucleic acids · 2023

“we observed the PPD0 adult skin cells, which lose their regenerative ability can self-organize in organoid culture and regenerate hair follicles robustly upon transplantation.”

Does not settle: This adult mouse organoid-transplantation study addresses hair-follicle regeneration only. It does not establish a distributed complete-skin micrograft composition, a restoration radius, graft number or coverage calculation, human transferability, eccrine gland or innervation integration, long-term maintenance, or replacement schedule.

S10Partly answers it

Human fetal skin derived merkel cells display distinctive characteristics in vitro and in bio-engineered skin substitutes in vivo. · Frontiers in bioengineering and biotechnology · 2022

“Merkel cells were present in freshly isolated human fetal epidermal cells in vitro , and in tissue-engineered human dermo-epidermal skin substitutes 4 weeks after transplantation on immune-compromised rats.”

Does not settle: This source does not establish restoration of surrounding skin by distributed complete micrografts, the required graft components, functional sensory or autonomic innervation, immune or vascular integration, gland or follicle function, graft spacing, radius of effect, coverage fraction, dosing, maintenance, or outcomes in humans.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Which skin treatment combinations sustain all required youthful functions for ten years compared with standard care?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Какие лечения и сочетания обеспечат выполнение всего при экспериментальном сравнении комбинаций, и десятилетнем наблюдении относительно стандартного ухода?

What this question is asking

The question concerns whether a complete treatment plan can bring middle-aged human skin to a younger functional state and maintain all required results for at least ten years. It asks which combinations of treatments, acting on which parts of the skin, meet every criterion in a set called compared with standard care. Comparing combinations and removing their components one at a time would distinguish a successful package from the parts needed for its success. The pipeline assumes that support for the skin’s structural layer and correction of its fats already have an evidence rating called , and that a sweat-gland mechanism has been described. Neither , , nor the content of standard care is defined in the supplied material.

What the terms mean
Q0
The pipeline’s label for the complete set of required results. Its contents are not supplied, so it cannot be equated with any particular measurement of youthful skin.
RL-2
An evidence rating used by the pipeline. Its definition and requirements are absent from the input.
Complete treatment regimen
The full treatment plan, including its components and how they are administered over time. A list of potentially useful treatments does not establish such a plan.
Tissue target
A part of the skin that a treatment is intended to affect. The question asks which such parts must be treated together.
Dermis and dermal support
The dermis is the skin’s structural layer. Dermal support names an intended treatment effect here, rather than a specified intervention.
Lipids and lipid correction
Lipids are a class of fats and related substances. The input does not specify which skin lipids require correction or what would count as correcting them.
Sweat glands
Structures that produce sweat. The pipeline refers to a mechanism involving them without supplying that mechanism.
Standard care
The usual care against which the proposed treatments would be compared. Its actual contents are not specified.
Component removal
Comparing a complete treatment combination with versions missing one component at a time. The question uses this comparison to ask which components are needed for the complete result.
Nicotinamide and excessive pigmentation
Nicotinamide is the substance applied to skin in S4, also called niacinamide in its title. Excessive pigmentation means increased skin coloration; the supplied evidence does not equate reducing it with restoring every skin function.
Messenger ribonucleic acid and type III collagen
Messenger ribonucleic acid carries instructions for making a protein; type III collagen is the structural protein targeted by the treatment in S8. The reported increase in collagen is one outcome, not a definition of complete restoration.
Oxidative stress and cellular senescence
Oxidative stress concerns damage associated with reactive chemicals in cells. Cellular senescence is a state in which cells stop dividing; S8 reports reducing both, without establishing that these changes meet every required functional criterion.
Microneedle fractional radiofrequency
The needle-based radiofrequency treatment compared in S9. The supplied material does not specify its operating settings or establish which skin functions it restores.
Basic fibroblast growth factor
The growth-signalling protein added to one treatment group in S9. The supplied quote identifies its use but does not report the added component’s effect.
Random assignment
Allocation of participants to comparison groups by chance. S9 reports this method, but a description of allocation alone does not establish a treatment outcome.
Autologous platelet concentrates
Preparations concentrating platelets from the same person who receives them; platelets are blood components involved in clotting and repair. These are the treatment class for which S3 calls for stronger evidence.
What the question takes for granted
Premise not found in what was read
Dermal support and lipid correction have support, and the sweat-gland node describes a mechanism.

The assumption concerns the dermis, the skin’s structural layer; lipids, the fats whose correction is proposed; and sweat glands, the structures that produce sweat. It says the first two already have a specified evidence rating and that a mechanism is available for the third, providing a starting point for asking whether treatments directed at these parts are sufficient together.

The supplied search results do not establish these evidence ratings or the claimed sweat-gland mechanism. S8 reports effects on collagen production and skin structure, which bears on structural support, but does not establish an undefined classification. S7 concerns using lipid particles to deliver a substance into skin; that does not establish correction of the skin’s own lipids. This lack of support in the supplied results does not establish that the premise is false.S7S8

The same question asked without the part nothing read establishes:

  • Which combinations of treatments directed at skin structure, skin fats and sweat glands meet every defined criterion for at least ten years compared with standard care?
  • Which complete skin treatment combinations meet every defined criterion for at least ten years compared with standard care, and which components are necessary for that result?
What turns on the answer
  • A complete combination meets every criterion This would establish a successful treatment package for the population, comparison and ten-year period actually assessed. Its individual components would count as necessary only where removing them caused the package to lose the required result.
  • Only some functions improve, or improvement fades The combination would deliver a limited benefit while failing the question’s requirement that every criterion remain satisfied. Describing it as complete restoration would conceal the unmet function or the loss of benefit over time.
  • Standard care performs equally well or better Meeting the criteria would not by itself establish an advantage for the treatment combination. Attribution of the result to the added treatments would remain unsupported by that comparison.
Why it matters

A treatment could improve one aspect of skin while leaving another required function unchanged. Combining treatments would satisfy the question only if all required results occurred together and persisted for the specified period. Removing a component concerns whether the remaining combination still delivers those results; improvement with a complete package alone cannot establish that every ingredient is necessary. Treating a limited or short-term improvement as proof of complete, lasting restoration would therefore overstate what the treatment delivers.

What is already established

Поддержка и имеют ; узел описывает . Совместная достаточность вмешательств отсутствует.

What would have to be true

Установленный набор с совместным выполнением всех критериев у участников на протяжении минимум 10 лет.

What is missing

Неизвестны состав успешного набора, необходимые и взаимодействия компонентов, определяющие принадлежность к этому набору.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Минимальный достаточный набор представляет собой пространственно распределённые полноценные . Каждый содержит , с , , , и структуры для подключения ; в областях с волосами и включается соответствующий . Проверяемая количественная версия: радиуса a восстанавливает окружающую кожу в радиусе R = 3a. Тогда на большой приблизительно плоской области площади A достаточно N ≈ 2A/(3√3R²) единиц с ; непосредственно заменяется около 13,площади кожи на глубину включённых структур. Первоначальный режим состоит из одного размещения единиц по и их . Поддержание включает стандартный ежедневный уход, ежегодное и максимум один сеанс замены утраченных единиц в год без увеличения исходного N. необходимы для восстановления клеточных исполнителей функций; меньшее число оставляет участки вне зоны восстановления, а исключение железистого или нервного компонента сохраняет соответствующий .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

Геометрия покрытия поверхности равными кругами: для расстояние между центрами d = √3R, S = √3d²/2 = 3√3R²/2. Поэтому N ≈ A/S и f = Nπa²/A ≈ [2π/(3√3)](a/R)². Здесь A представляет площадь кожи, подлежащую восстановлению; a представляет физический радиус ; R представляет предполагаемый радиус полноценного функционального восстановления вокруг него; d представляет расстояние между центрами; S представляет площадь кожи на одну единицу; N представляет число единиц; f представляет непосредственно заменяемую долю площади. При R = 3a получается f ≈ 0,1344. Формулы следуют из площади равностороннего треугольника и радиуса его . Для конечной изогнутой поверхности требуется отдельный расчёт покрытия с и анатомических ограничений. Биологическое равенство R = 3a является самостоятельной проверяемой гипотезой, а не следствием геометрии.

What a later run added

A later run reached the same claim about the same subject. Its version was withdrawn in favour of this earlier one, and what it added is kept here, quoted exactly.

An idea from another field

Для устойчивого однородного состояния без диффузии, которое становится неустойчивым при пространственных возмущениях, наиболее быстро растущая мода k* задаёт характерный шаг λ* = 2π/k*.

Adds a reaction–diffusion mechanism for determining characteristic spacing, whereas EARLIER uses geometric coverage with an assumed restoration radius.

A sharper prediction

Если S восстанавливает весь функциональный профиль без такой реконструкции, необходимость набора M опровергнута.

Adds secretory stimulation alone as a specific competing intervention capable of falsifying the claimed necessity of reconstruction; EARLIER instead names acellular matrix restoration.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковом числе и составе равномерное размещение обеспечивает совместное восстановление функций по всей исследуемой области, а размещение группами оставляет воспроизводимые в промежутках. Границы провалов определяются расстоянием до ближайшей и возникают за пределами 3a. Изолированная коррекция улучшает , но сохраняет хотя бы часть или нарушений. Если одинаковый результат даёт , необходимость полноценного клеточного набора опровергнута. Если эффект остаётся только внутри , опровергнута количественная версия о достаточности 13,площади.

Would tell it apart from at least one rival. The prediction specifies observable functional and spatial comparisons, a distance threshold, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Биологическая предпосылка частична: человеческие уже объединяли , и . Это не демонстрация зрелой кожи со всеми функциями . [Lee и соавт., 2020](https://www.nature.com/articles/s41586-020-2352-3). Геометрическое сравнение размещений выполнимо на моделях; получение безопасного полноценного , его и восстановление соседней возрастной кожи остаются необходимыми этапами разработки.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковом числе и составе равномерное размещение обеспечивает совместное восстановление функций по всей исследуемой области, а размещение группами оставляет воспроизводимые в промежутках. Границы провалов определяются расстоянием до ближайшей и возникают за пределами 3a. Изолированная коррекция улучшает , но сохраняет хотя бы часть или нарушений. Если одинаковый результат даёт , необходимость полноценного клеточного набора опровергнута. Если эффект остаётся только внутри , опровергнута количественная версия о достаточности 13,4% площади.

  • What would separate them

    Repairing all three skin matrix components may restore function without replacing cells predicts: После подтверждённого восстановления трёх компонентов нормализуются также , потоотделение и при сохранении исходных . Добавление не увеличивает долю участников с совместным успехом сверх заранее установленной . Поочерёдное исключение коррекции , или нарушает совместный успех. Сохранение либо дефицита при успешно восстановленном опровергает достаточность этого набора и поддерживает необходимость клеточных компонентов конкурирующего набора.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

2 quantitative figures appear below and the hypothesis cites no study for any of them. They are the engine's own, and the marks in the text say which.

CitationsCites nothingFigures2 of 2 uncarriedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

6 papers retrieved around this hypothesis
  • Housing displacement experiences following major flooding in regional Australia: A qualitative study of online news articles.PMID 42715233 · full_text · 89,757 characters stored
  • Ten-year analysis of publications by Quebec hospital pharmacistseuropepmc:PMC:PMC13446782 · full_text · 3,860 characters stored
  • Special Issue Editorial: "Antibacterial Agents from Natural Source, 2nd Edition".PMID 42738736 · full_text · 10,220 characters stored
  • SARD: A Large-Scale Synthetic Arabic OCR Dataset for Book-Style Text Recognition.PMID 42760300 · full_text · 36,079 characters stored
  • Characterizing Food Industry Affiliations Among Critics of the Nova Food Classification System: A Systematic Review.PMID 42753229 · full_text · 5,813 characters stored
  • Something looks fishy! A philosophical exploration of AI for marine conservation.PMID 42687934 · full_text · 91,449 characters stored

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.